These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

327 related items for PubMed ID: 9049229

  • 1. Pretreatment virus load and multiple amino acid substitutions in the interferon sensitivity-determining region predict the outcome of interferon treatment in patients with chronic genotype 1b hepatitis C virus infection.
    Chayama K, Tsubota A, Kobayashi M, Okamoto K, Hashimoto M, Miyano Y, Koike H, Kobayashi M, Koida I, Arase Y, Saitoh S, Suzuki Y, Murashima N, Ikeda K, Kumada H.
    Hepatology; 1997 Mar; 25(3):745-9. PubMed ID: 9049229
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Interferon sensitivity-determining region of nonstructural region 5A of hepatitis C virus genotype 1b correlates with serum alanine aminotransferase levels in chronic infection.
    Yoshioka K, Ito H, Watanabe K, Yano M, Ishigami M, Mizutani T, Sasaki Y, Goto H.
    J Viral Hepat; 2005 Mar; 12(2):139-45. PubMed ID: 15720528
    [Abstract] [Full Text] [Related]

  • 6. Analysis of genotypes and amino acid residues 2209 to 2248 of the NS5A region of hepatitis C virus in relation to the response to interferon-beta therapy.
    Kurosaki M, Enomoto N, Murakami T, Sakuma I, Asahina Y, Yamamoto C, Ikeda T, Tozuka S, Izumi N, Marumo F, Sato C.
    Hepatology; 1997 Mar; 25(3):750-3. PubMed ID: 9049230
    [Abstract] [Full Text] [Related]

  • 7. Predictive factors of virological non-response to interferon-ribavirin combination therapy for patients infected with hepatitis C virus of genotype 1b and high viral load.
    Akuta N, Suzuki F, Sezaki H, Suzuki Y, Hosaka T, Someya T, Kobayashi M, Saitoh S, Watahiki S, Sato J, Kobayashi M, Arase Y, Ikeda K, Kumada H.
    J Med Virol; 2006 Jan; 78(1):83-90. PubMed ID: 16299715
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Structural analysis of the PKR-binding region of HCV 1b samples from patients with chronic hepatitis C and the correlation with IFN-sensitivity].
    Gervain J, Czibula A, Simon J, Kalmár T.
    Orv Hetil; 2003 Jun 15; 144(24):1179-84. PubMed ID: 12866147
    [Abstract] [Full Text] [Related]

  • 12. Mutations in interferon sensitivity-determining region of hepatitis C virus: its relation to change in viral load.
    Terazawa Y, Yoshioka K, Kobayashi M, Watanabe K, Ishigami M, Yano M, Takagi K, Kakumu S.
    Am J Gastroenterol; 2000 Jul 15; 95(7):1781-7. PubMed ID: 10925985
    [Abstract] [Full Text] [Related]

  • 13. Nucleotide sequence variations in the internal ribosome entry site of hepatitis C virus-1b: no association with efficacy of interferon therapy or serum HCV-RNA levels.
    Yamamoto C, Enomoto N, Kurosaki M, Yu SH, Tazawa J, Izumi N, Marumo F, Sato C.
    Hepatology; 1997 Dec 15; 26(6):1616-20. PubMed ID: 9398006
    [Abstract] [Full Text] [Related]

  • 14. Efficacy of human leucocyte alpha-interferon treatment for chronic hepatitis C virus infection.
    Weiland O, Chen M, Lindh G, Mattsson L, Schvarcz R, Sönnerborg A, Wahl M, Wejstål R, Widell A, Norkrans G.
    Scand J Infect Dis; 1995 Dec 15; 27(4):319-24. PubMed ID: 8658063
    [Abstract] [Full Text] [Related]

  • 15. A mutation in the interferon sensitivity-determining region is associated with responsiveness to interferon-ribavirin combination therapy in chronic hepatitis patients infected with a Japan-specific subtype of hepatitis C virus genotype 1B.
    Murayama M, Katano Y, Nakano I, Ishigami M, Hayashi K, Honda T, Hirooka Y, Itoh A, Goto H.
    J Med Virol; 2007 Jan 15; 79(1):35-40. PubMed ID: 17133546
    [Abstract] [Full Text] [Related]

  • 16. Interferon treatment for patients with chronic hepatitis C infected with high viral load of genotype 2 virus.
    Nakamura H, Ogawa H, Kuroda T, Yamamoto M, Enomoto H, Kishima Y, Yoshida K, Ito H, Matsuda M, Noguchi S.
    Hepatogastroenterology; 2002 Jan 15; 49(47):1373-6. PubMed ID: 12239945
    [Abstract] [Full Text] [Related]

  • 17. Method to detect substitutions in the interferon-sensitivity-determining region of hepatitis C virus 1b for prediction of response to interferon therapy.
    Nishiguchi S, Ueda T, Itoh T, Enomoto M, Tanaka M, Tatsumi N, Fukuda K, Tamori A, Habu D, Takeda T, Otani S, Shiomi S.
    Hepatology; 2001 Jan 15; 33(1):241-7. PubMed ID: 11124842
    [Abstract] [Full Text] [Related]

  • 18. Efficacy of low-dose intermittent interferon-alpha monotherapy in patients infected with hepatitis C virus genotype 1b who were predicted or failed to respond to pegylated interferon plus ribavirin combination therapy.
    Akuta N, Suzuki F, Kawamura Y, Yatsuji H, Sezaki H, Suzuki Y, Hosaka T, Kobayashi M, Kobayashi M, Arase Y, Ikeda K, Kumada H.
    J Med Virol; 2008 Aug 15; 80(8):1363-9. PubMed ID: 18551610
    [Abstract] [Full Text] [Related]

  • 19. Sequence analysis of PePHD within HCV E2 region and correlation with resistance of interferon therapy in Japanese patients infected with HCV genotypes 2a and 2b.
    Saito T, Ito T, Ishiko H, Yonaha M, Morikawa K, Miyokawa A, Mitamura K.
    Am J Gastroenterol; 2003 Jun 15; 98(6):1377-83. PubMed ID: 12818284
    [Abstract] [Full Text] [Related]

  • 20. Association with 5'-untranslated region and response to interferon in chronic hepatitis C.
    Katano Y, Hayashi K, Ishigami M, Itoh A, Hirooka Y, Nakano I, Goto H.
    Hepatogastroenterology; 2007 Jun 15; 54(75):854-7. PubMed ID: 17591078
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.